Karagiannakos, A.; Adamaki, M.; Tsintarakis, A.; Vojtesek, B.; FÃ¥hraeus, R.; Zoumpourlis, V.; Karakostis, K.
Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets. Cancers 2022, 14, 664.
https://doi.org/10.3390/cancers14030664
AMA Style
Karagiannakos A, Adamaki M, Tsintarakis A, Vojtesek B, FÃ¥hraeus R, Zoumpourlis V, Karakostis K.
Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets. Cancers. 2022; 14(3):664.
https://doi.org/10.3390/cancers14030664
Chicago/Turabian Style
Karagiannakos, Alexandros, Maria Adamaki, Antonis Tsintarakis, Borek Vojtesek, Robin FÃ¥hraeus, Vassilis Zoumpourlis, and Konstantinos Karakostis.
2022. "Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets" Cancers 14, no. 3: 664.
https://doi.org/10.3390/cancers14030664
APA Style
Karagiannakos, A., Adamaki, M., Tsintarakis, A., Vojtesek, B., FÃ¥hraeus, R., Zoumpourlis, V., & Karakostis, K.
(2022). Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets. Cancers, 14(3), 664.
https://doi.org/10.3390/cancers14030664